当前位置：
X-MOL 学术
›
N. Engl. J. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2017-08-27 , DOI: 10.1056/nejmoa1706443 David Erlinge , Elmir Omerovic , Ole Fröbert , Rikard Linder , Mikael Danielewicz , Mehmet Hamid , Eva Swahn , Loghman Henareh , Henrik Wagner , Peter Hårdhammar , Iwar Sjögren , Jason Stewart , Per Grimfjärd , Jens Jensen , Mikael Aasa , Lotta Robertsson , Pontus Lindroos , Jan Haupt , Helena Wikström , Anders Ulvenstam , Pallonji Bhiladvala , Bo Lindvall , Anders Lundin , Tim Tödt , Dan Ioanes , Truls Råmunddal , Thomas Kellerth , Leszek Zagozdzon , Matthias Götberg , Jonas Andersson , Oskar Angerås , Ollie Östlund , Bo Lagerqvist , Claes Held , Lars Wallentin , Fredrik Scherstén , Peter Eriksson , Sasha Koul , Stefan James
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2017-08-27 , DOI: 10.1056/nejmoa1706443 David Erlinge , Elmir Omerovic , Ole Fröbert , Rikard Linder , Mikael Danielewicz , Mehmet Hamid , Eva Swahn , Loghman Henareh , Henrik Wagner , Peter Hårdhammar , Iwar Sjögren , Jason Stewart , Per Grimfjärd , Jens Jensen , Mikael Aasa , Lotta Robertsson , Pontus Lindroos , Jan Haupt , Helena Wikström , Anders Ulvenstam , Pallonji Bhiladvala , Bo Lindvall , Anders Lundin , Tim Tödt , Dan Ioanes , Truls Råmunddal , Thomas Kellerth , Leszek Zagozdzon , Matthias Götberg , Jonas Andersson , Oskar Angerås , Ollie Östlund , Bo Lagerqvist , Claes Held , Lars Wallentin , Fredrik Scherstén , Peter Eriksson , Sasha Koul , Stefan James
|
Among patients undergoing PCI for myocardial infarction, the rate of the composite of death from any cause, myocardial infarction, or major bleeding was not lower among those who received bivalirudin than among those who received heparin monotherapy. (Funded by the Swedish Heart–Lung Foundation and others; VALIDATE-SWEDEHEART ClinicalTrialsRegister.eu number, 2012-005260-10; ClinicalTrials.gov number, NCT02311231.)
中文翻译：
比伐卢定与肝素单药治疗心肌梗死
在接受PCI治疗心肌梗死的患者中，接受比伐卢定治疗的患者因任何原因，心肌梗塞或重大出血而死亡的复合率并不低于接受肝素单药治疗的患者。（由瑞典心肺基金会和其他机构资助； VALIDATE-SWEDEHEART ClinicalTrialsRegister.eu号，2012-005260-10； ClinicalTrials.gov号，NCT02311231。）
更新日期：2017-09-20
中文翻译：
比伐卢定与肝素单药治疗心肌梗死
在接受PCI治疗心肌梗死的患者中，接受比伐卢定治疗的患者因任何原因，心肌梗塞或重大出血而死亡的复合率并不低于接受肝素单药治疗的患者。（由瑞典心肺基金会和其他机构资助； VALIDATE-SWEDEHEART ClinicalTrialsRegister.eu号，2012-005260-10； ClinicalTrials.gov号，NCT02311231。）
京公网安备 11010802027423号